Cargando…

An IRF1-IRF4 Toggle-Switch Controls Tolerogenic and Immunogenic Transcriptional Programming in Human Langerhans Cells

Langerhans cells (LCs) reside in the epidermis as a dense network of immune system sentinels, coordinating both immunogenic and tolerogenic immune responses. To determine molecular switches directing induction of LC immune activation, we performed mathematical modelling of gene regulatory networks i...

Descripción completa

Detalles Bibliográficos
Autores principales: Davies, James, Vallejo, Andres F., Sirvent, Sofia, Porter, Gemma, Clayton, Kalum, Qumbelo, Yamkela, Stumpf, Patrick, West, Jonathan, Gray, Clive M., Chigorimbo-Murefu, Nyaradzo T. L., MacArthur, Ben, Polak, Marta E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239435/
https://www.ncbi.nlm.nih.gov/pubmed/34211464
http://dx.doi.org/10.3389/fimmu.2021.665312
_version_ 1783715077008916480
author Davies, James
Vallejo, Andres F.
Sirvent, Sofia
Porter, Gemma
Clayton, Kalum
Qumbelo, Yamkela
Stumpf, Patrick
West, Jonathan
Gray, Clive M.
Chigorimbo-Murefu, Nyaradzo T. L.
MacArthur, Ben
Polak, Marta E.
author_facet Davies, James
Vallejo, Andres F.
Sirvent, Sofia
Porter, Gemma
Clayton, Kalum
Qumbelo, Yamkela
Stumpf, Patrick
West, Jonathan
Gray, Clive M.
Chigorimbo-Murefu, Nyaradzo T. L.
MacArthur, Ben
Polak, Marta E.
author_sort Davies, James
collection PubMed
description Langerhans cells (LCs) reside in the epidermis as a dense network of immune system sentinels, coordinating both immunogenic and tolerogenic immune responses. To determine molecular switches directing induction of LC immune activation, we performed mathematical modelling of gene regulatory networks identified by single cell RNA sequencing of LCs exposed to TNF-alpha, a key pro-inflammatory signal produced by the skin. Our approach delineated three programmes of LC phenotypic activation (immunogenic, tolerogenic or ambivalent), and confirmed that TNF-alpha enhanced LC immunogenic programming. Through regulon analysis followed by mutual information modelling, we identified IRF1 as the key transcription factor for the regulation of immunogenicity in LCs. Application of a mathematical toggle switch model, coupling IRF1 with tolerance-inducing transcription factors, determined the key set of transcription factors regulating the switch between tolerance and immunogenicity, and correctly predicted LC behaviour in LCs derived from different body sites. Our findings provide a mechanistic explanation of how combinatorial interactions between different transcription factors can coordinate specific transcriptional programmes in human LCs, interpreting the microenvironmental context of the local tissue microenvironments.
format Online
Article
Text
id pubmed-8239435
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82394352021-06-30 An IRF1-IRF4 Toggle-Switch Controls Tolerogenic and Immunogenic Transcriptional Programming in Human Langerhans Cells Davies, James Vallejo, Andres F. Sirvent, Sofia Porter, Gemma Clayton, Kalum Qumbelo, Yamkela Stumpf, Patrick West, Jonathan Gray, Clive M. Chigorimbo-Murefu, Nyaradzo T. L. MacArthur, Ben Polak, Marta E. Front Immunol Immunology Langerhans cells (LCs) reside in the epidermis as a dense network of immune system sentinels, coordinating both immunogenic and tolerogenic immune responses. To determine molecular switches directing induction of LC immune activation, we performed mathematical modelling of gene regulatory networks identified by single cell RNA sequencing of LCs exposed to TNF-alpha, a key pro-inflammatory signal produced by the skin. Our approach delineated three programmes of LC phenotypic activation (immunogenic, tolerogenic or ambivalent), and confirmed that TNF-alpha enhanced LC immunogenic programming. Through regulon analysis followed by mutual information modelling, we identified IRF1 as the key transcription factor for the regulation of immunogenicity in LCs. Application of a mathematical toggle switch model, coupling IRF1 with tolerance-inducing transcription factors, determined the key set of transcription factors regulating the switch between tolerance and immunogenicity, and correctly predicted LC behaviour in LCs derived from different body sites. Our findings provide a mechanistic explanation of how combinatorial interactions between different transcription factors can coordinate specific transcriptional programmes in human LCs, interpreting the microenvironmental context of the local tissue microenvironments. Frontiers Media S.A. 2021-06-15 /pmc/articles/PMC8239435/ /pubmed/34211464 http://dx.doi.org/10.3389/fimmu.2021.665312 Text en Copyright © 2021 Davies, Vallejo, Sirvent, Porter, Clayton, Qumbelo, Stumpf, West, Gray, Chigorimbo-Murefu, MacArthur and Polak https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Davies, James
Vallejo, Andres F.
Sirvent, Sofia
Porter, Gemma
Clayton, Kalum
Qumbelo, Yamkela
Stumpf, Patrick
West, Jonathan
Gray, Clive M.
Chigorimbo-Murefu, Nyaradzo T. L.
MacArthur, Ben
Polak, Marta E.
An IRF1-IRF4 Toggle-Switch Controls Tolerogenic and Immunogenic Transcriptional Programming in Human Langerhans Cells
title An IRF1-IRF4 Toggle-Switch Controls Tolerogenic and Immunogenic Transcriptional Programming in Human Langerhans Cells
title_full An IRF1-IRF4 Toggle-Switch Controls Tolerogenic and Immunogenic Transcriptional Programming in Human Langerhans Cells
title_fullStr An IRF1-IRF4 Toggle-Switch Controls Tolerogenic and Immunogenic Transcriptional Programming in Human Langerhans Cells
title_full_unstemmed An IRF1-IRF4 Toggle-Switch Controls Tolerogenic and Immunogenic Transcriptional Programming in Human Langerhans Cells
title_short An IRF1-IRF4 Toggle-Switch Controls Tolerogenic and Immunogenic Transcriptional Programming in Human Langerhans Cells
title_sort irf1-irf4 toggle-switch controls tolerogenic and immunogenic transcriptional programming in human langerhans cells
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239435/
https://www.ncbi.nlm.nih.gov/pubmed/34211464
http://dx.doi.org/10.3389/fimmu.2021.665312
work_keys_str_mv AT daviesjames anirf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells
AT vallejoandresf anirf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells
AT sirventsofia anirf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells
AT portergemma anirf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells
AT claytonkalum anirf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells
AT qumbeloyamkela anirf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells
AT stumpfpatrick anirf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells
AT westjonathan anirf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells
AT grayclivem anirf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells
AT chigorimbomurefunyaradzotl anirf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells
AT macarthurben anirf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells
AT polakmartae anirf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells
AT daviesjames irf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells
AT vallejoandresf irf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells
AT sirventsofia irf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells
AT portergemma irf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells
AT claytonkalum irf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells
AT qumbeloyamkela irf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells
AT stumpfpatrick irf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells
AT westjonathan irf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells
AT grayclivem irf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells
AT chigorimbomurefunyaradzotl irf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells
AT macarthurben irf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells
AT polakmartae irf1irf4toggleswitchcontrolstolerogenicandimmunogenictranscriptionalprogramminginhumanlangerhanscells